MDAI Spectral AI, Inc.
USHealthcareAs of 2026-07-10 16:00
Why MDAI matters now
Spectral AI, Inc. (MDAI) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.72 with +0.00% on the session and $54.7M in market capitalization; recent performance reads 1-month -23.21% and YTD +28.17%.
The latest financial table shown here is Q1 2026, with revenue of $4.0M, net income of $-3.4M, and EPS of $-0.11. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -21.0%.
The latest indexable market news headline is "Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $4.00; recent insider activity includes DiMaio John Michael filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-6.56
P/S
3.47
EV/EBITDA
-4.42
DCF Value
$-6.15
FCF Yield
-21.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
44.7%
Operating Margin
-59.4%
Net Margin
-85.6%
ROE
179.2%
ROA
-80.6%
ROIC
-876.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $4.0M | $-3.4M | $-0.11 |
| Q4 2025 | $3.8M | $642.0K | $0.02 |
| FY 2025 | $19.6M | $-7.6M | $-0.29 |
| Q3 2025 | $3.8M | $-3.6M | $-0.13 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$4.00
Target (Median)
$4.00
Target Range
$4.00 - $4.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.15
Spectral AI, Inc. is an artificial intelligence (AI) firm specializing in AI-driven medical diagnostics. The company's primary goal is to facilitate faster and more accurate treatment decisions in wound care, particularly for patients dealing with burns and diabetic foot ulcers. Among its key products is DeepView, a predictive diagnostic device that delivers an objective and immediate evaluation of a wound's likely healing trajectory to clinicians, prior to any medical treatment or intervention. Spectral AI, Inc. is headquartered in Dallas, Texas.